Events

As Co-founder and Chief Scientific Officer of #VivetTherapeutics, Dr @Gloria Gonzalez-Aseguinolaza will be presenting 📢 at the upcoming #CTX Scientific & Family Meeting

🎓Are you attending the upcoming @EASL Congress 2024, the home of Hepatology, from 5-8 June in Milan, Italy! Don’t miss the opportunity to meet the

Join Sonia VALERO, Head of Clinical Operations and Patient Advocacy Representative at Vivet Therapeutics’ at the 4th Annual Gene Therapy Patient Engagement Summit in Boston,

Join us in London next week at the 5th Annual Gene Therapy Analytical Development Europe Summit, 22-24 May, where our Chief Operating Officer, @Anne Douar

📢 Listen in as @Vivet Therapeutics Co-founder and Chief Scientific Officer, @Gloria Gonzalez-Aseguinolaza participates in a round table discussion at the Genome Regulation and Cellular

Don’t miss the opportunity to connect with our CEO @Jean-Philippe Combal & General Counsel & Head of Finance @Susan Coles at #BioEquity Europe 2024, from

Save the date! We are presenting at the 27th Annual @American Society of Gene & Cell Therapy (#ASGCT) Meeting next week in Baltimore, MD! 📌

We’re thrilled to share that our CEO Jean-Philippe Combal will join a panel of key industry leaders at the 10th Annual LSX World Congress to provide insight on best

Paris, France, April 23, 2024 – Vivet Therapeutics (“Vivet”), a clinical stage biotech company developing novel and long-lasting gene therapies for rare inherited liver metabolic

Vivet Therapeutics Co-founder and Chief Scientific Officer, Gloria Gonzalez-Aseguinolaza will be participating in a round table discussion on ‘Therapeutic Advances’ on the ‘Current Situation of